Abiopharma

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0000950103-26-005976 <b>Size:</b> 314 KB

Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy

CADELER A/S (CDLR) Files Form 6-K

ICECURE MEDICAL LTD. (ICCM) Files Form 6-K

MIXED MARTIAL ARTS GROUP LTD (MMA) Files Form 6-K

Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call

NYSE: MMA Highlights 41-Pound Health Transformation at UFC GYM Through TrainAlta

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0001193125-26-165660 <b>Size:</b> 239 KB

WEBULL CORP (BULLW) Files Form 6-K

(99% Neutral) OFG BANCORP (OFG) Reports Q2 2026 Financial Results

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0000950103-26-005975 <b>Size:</b> 519 KB

Moleculin Announces Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting

FDIC 2026: MSA Safety Advances Firefighter Protection for a More Complex Fireground

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0001140361-26-015838 <b>Size:</b> 392 KB

SAVERONE 2014 LTD (SVRE) Files Form 6-K